Regeneron Pharmaceuticals (REGN) Short Interest Ratio & Short Volume $838.20 -84.59 (-9.17%) (As of 10/31/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Regeneron Pharmaceuticals Short Interest DataRegeneron Pharmaceuticals (REGN) has a short interest of 1.72 million shares. This marks a -0.58% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 514,941 shares to cover all short positions.Current Short Interest1,720,000 sharesPrevious Short Interest1,730,000 sharesChange Vs. Previous Month-0.58%Dollar Volume Sold Short$1.75 billionShort Interest Ratio3.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares110,235,000 sharesPercentage of Shares Shorted1.56%Today's Trading Volume2,291,449 sharesAverage Trading Volume514,941 sharesToday's Volume Vs. Average445% Short Selling Regeneron Pharmaceuticals? Sign up to receive the latest short interest report for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartREGN Short Interest Over TimeREGN Days to Cover Over TimeREGN Percentage of Float Shorted Over Time Ad Crypto Swap Profits24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast world of passive crypto income, where you set up a dependable income stream that works for you, whether you're at your computer or living your life.>> Secure Your Spot On The Groundbreaking Workshop Here Regeneron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20241,720,000 shares $1.75 billion -0.6%N/A3 $1,016.53 9/30/20241,730,000 shares $1.82 billion -12.6%N/A3.3 $1,051.24 9/15/20241,980,000 shares $2.28 billion -5.7%N/A4.1 $1,153.35 8/31/20242,100,000 shares $2.49 billion -0.5%N/A4.6 $1,184.69 8/15/20242,110,000 shares $2.48 billion +5.0%N/A4.7 $1,175.33 7/31/20242,010,000 shares $2.17 billion +6.4%N/A4.6 $1,079.19 Get the Latest News and Ratings for REGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regeneron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/20241,890,000 shares $2.05 billion -7.4%N/A4.3 $1,082.11 6/30/20242,040,000 shares $2.14 billion +10.3%N/A4.5 $1,051.03 6/15/20241,850,000 shares $1.92 billion +5.7%N/A4.1 $1,036.52 5/31/20241,750,000 shares $1.72 billion +7.4%N/A4 $980.16 5/15/20241,630,000 shares $1.59 billion +3.8%N/A3.7 $978.21 4/30/20241,570,000 shares $1.40 billion +13.0%N/A3.4 $890.66 4/15/20241,390,000 shares $1.25 billion -2.1%N/A3 $898.56 3/31/20241,420,000 shares $1.37 billion +2.2%N/A3 $962.49 3/15/20241,390,000 shares $1.34 billion +2.2%N/A2.7 $964.47 2/29/20241,360,000 shares $1.31 billion -0.7%N/A2.4 $966.09 2/15/20241,370,000 shares $1.31 billion +9.6%N/A2.4 $954.73 1/31/20241,250,000 shares $1.18 billion +16.8%N/A2.2 $942.78 1/15/20241,070,000 shares $998.52 million +0.9%1.0%1.9 $933.20 12/31/20231,060,000 shares $930.99 million -13.1%1.0%2 $878.29 12/15/20231,220,000 shares $1.05 billion -0.8%1.2%2.4 $859.14 11/30/20231,230,000 shares $1.01 billion -12.1%1.2%2.7 $823.81 11/15/20231,400,000 shares $1.11 billion +6.9%1.3%3.3 $792.38 10/31/20231,310,000 shares $1.02 billion -4.4%1.3%3 $779.89 10/15/20231,370,000 shares $1.15 billion +16.1%1.3%3 $839.63 9/30/20231,180,000 shares $971.09 million -18.6%1.1%2.4 $822.96 9/15/20231,450,000 shares $1.19 billion -2.0%1.4%2.5 $823.40 8/31/20231,480,000 shares $1.22 billion +8.8%1.4%2.5 $826.49 8/15/20231,360,000 shares $1.10 billion +1.5%1.3%2.1 $805.91 7/31/20231,340,000 shares $994.16 million +5.5%1.3%2.1 $741.91 7/15/20231,270,000 shares $912.52 million +17.6%N/A2 $718.52 6/30/20231,080,000 shares $776.02 million -12.2%N/A1.8 $718.54 6/15/20231,230,000 shares $963.18 million +7.9%N/A2.2 $783.07 5/31/20231,140,000 shares $838.54 million -5.8%N/A2 $735.56 5/15/20231,210,000 shares $908.66 million +2.5%N/A2.1 $750.96 4/30/20231,180,000 shares $946.11 million -2.5%1.1%2 $801.79 4/15/20231,210,000 shares $1.00 billion -6.9%1.2%2 $829.33 3/31/20231,300,000 shares $1.07 billion +7.4%1.2%2 $821.67 3/15/20231,210,000 shares $919.96 million +0.8%1.2%1.9 $760.30 2/28/20231,200,000 shares $912.50 million -10.5%1.2%1.9 $760.42Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 2/15/20231,340,000 shares $1.01 billion -8.2%1.3%2.1 $752.40 1/31/20231,460,000 shares $1.11 billion +3.6%1.4%2.2 $758.47 1/15/20231,410,000 shares $1.02 billion -6.0%1.4%2.2 $722.13 12/30/20221,500,000 shares $1.08 billion +4.2%1.5%2.2 $721.49 12/15/20221,440,000 shares $1.05 billion -7.1%1.4%2.1 $731.27 11/30/20221,550,000 shares $1.17 billion -11.9%1.5%2.1 $751.70 11/15/20221,760,000 shares $1.28 billion -0.6%1.7%2.3 $728.73 10/31/20221,770,000 shares $1.33 billion -16.1%1.7%2.3 $748.75 10/15/20222,110,000 shares $1.55 billion -7.5%2.1%2.8 $736.06 9/30/20222,280,000 shares $1.57 billion -3.8%2.2%3.2 $688.87 9/15/20222,370,000 shares $1.67 billion -18.6%2.3%3.5 $705.85 8/31/20222,910,000 shares $1.69 billion -0.7%2.8%4.3 $581.06 8/15/20222,930,000 shares $1.88 billion -4.6%2.9%4.6 $643.29 7/31/20223,070,000 shares $1.79 billion +7.3%3.0%4.6 $581.69 7/15/20222,860,000 shares $1.74 billion +3.3%2.8%4.3 $607.54 6/30/20222,770,000 shares $1.64 billion +7.4%N/A4.1 $591.13 6/15/20222,580,000 shares $1.45 billion +23.4%N/A3.7 $561.19 5/31/20222,090,000 shares $1.39 billion -4.1%N/A3.1 $664.74 5/15/20222,180,000 shares $1.41 billion +0.9%N/A3.4 $645.52 4/30/20222,160,000 shares $1.42 billion +0.5%N/A3.2 $659.11 4/15/20222,150,000 shares $1.58 billion -2.3%2.1%3 $733.02 3/31/20222,200,000 shares $1.54 billion -8.0%2.1%3 $698.42 3/15/20222,390,000 shares $1.59 billion +6.7%2.3%3.3 $665.93 2/28/20222,240,000 shares $1.39 billion +4.7%2.2%3 $618.36 2/15/20222,140,000 shares $1.35 billion +19.6%2.1%2.8 $630.15 1/31/20221,790,000 shares $1.09 billion -1.7%1.7%2.4 $608.59 1/15/20221,820,000 shares $1.12 billion +11.0%1.8%2.4 $615.24 12/31/20211,640,000 shares $1.04 billion +7.2%1.6%2.2 $631.52 12/15/20211,530,000 shares $1.01 billion +3.4%1.5%1.9 $657.93 11/30/20211,480,000 shares $942.06 million -8.1%1.4%2 $636.53 11/15/20211,610,000 shares $1.04 billion -14.4%1.6%2.1 $647.73 10/29/20211,880,000 shares $1.20 billion +6.8%1.8%2.3 $639.94 10/15/20211,760,000 shares $973.70 million -2.2%1.7%2.2 $553.24 9/30/20211,800,000 shares $1.09 billion +14.7%1.8%2.4 $605.18 9/15/20211,570,000 shares $1.02 billion +15.4%1.5%2 $652.00 8/31/20211,360,000 shares $915.82 million -3.6%1.3%1.7 $673.40 8/13/20211,410,000 shares $880.95 million -11.3%1.4%1.8 $624.79 7/30/20211,590,000 shares $913.63 million -13.6%1.6%2.1 $574.61 7/15/20211,840,000 shares $1.08 billion +30.5%1.8%2.4 $589.32 6/30/20211,410,000 shares $787.54 million -26.6%1.4%1.8 $558.54 6/15/20211,920,000 shares $1.01 billion -9.0%1.9%2.4 $527.49 5/28/20212,110,000 shares $1.06 billion -5.4%2.1%2.6 $502.43 5/14/20212,230,000 shares $1.15 billion -4.7%2.2%2.6 $517.17 4/30/20212,340,000 shares $1.13 billion -14.9%2.3%2.5 $485.00 4/15/20212,750,000 shares $1.32 billion +24.4%2.7%2.8 $481.16 3/31/20212,210,000 shares $1.04 billion -16.9%2.2%2.1 $470.67 3/15/20212,660,000 shares $1.25 billion +14.7%2.6%2.6 $471.46 2/26/20212,320,000 shares $1.05 billion +10.0%2.3%2.2 $453.19 2/12/20212,110,000 shares $1.04 billion +8.8%2.1%2 $490.54 1/29/20211,940,000 shares $982.16 million -18.8%1.9%2 $506.27Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 1/15/20212,390,000 shares $1.24 billion +6.2%2.4%2.6 $517.91 12/31/20202,250,000 shares $1.08 billion +14.8%2.2%2.4 $478.30 12/15/20201,960,000 shares $980.74 million -8.0%1.9%1.9 $500.38 11/30/20202,130,000 shares $1.09 billion +6.0%2.1%2.2 $514.05 11/15/20202,010,000 shares $1.14 billion -7.4%2.0%2.1 $566.43 10/30/20202,170,000 shares $1.21 billion -6.9%2.1%2.4 $555.79 10/15/20202,330,000 shares $1.40 billion +13.7%2.3%2.7 $600.82 9/30/20202,050,000 shares $1.15 billion +28.1%2.0%2.4 $559.78 9/15/20201,600,000 shares $927.84 million +0.6%1.6%2.1 $579.90 8/31/20201,590,000 shares $985.69 million -0.6%1.6%2 $619.93 8/14/20201,600,000 shares $980.11 million -15.3%1.6%1.4 $612.57 7/31/20201,890,000 shares $1.19 billion -5.0%1.9%1.5 $632.07 7/15/20201,990,000 shares $1.28 billion -6.1%1.9%1.5 $641.23 6/30/20202,120,000 shares $1.32 billion -14.2%2.0%1.5 $623.65 6/15/20202,470,000 shares $1.46 billion +24.1%2.3%1.7 $590.57 5/29/20201,990,000 shares $1.22 billion +11.8%1.9%1.3 $612.81 5/15/20201,780,000 shares $1.03 billion -4.8%2.1%1.2 $576.72 4/30/20201,870,000 shares $983.40 million -7.0%2.2%1.4 $525.88 4/15/20202,010,000 shares $1.03 billion +12.9%2.5%1.5 $511.69 3/31/20201,780,000 shares $1.01 billion -30.4%2.2%1.4 $566.21 3/13/20202,558,900 shares $1.31 billion -11.2%3.1%2 $512.96 2/28/20202,880,000 shares $1.31 billion +8.7%3.5%2.9 $455.63 2/14/20202,650,000 shares $1.26 billion -8.3%3.2%3 $475.02 1/31/20202,890,000 shares $1.32 billion +10.3%3.5%3.5 $457.92 1/15/20202,620,000 shares $1.04 billion +5.7%3.2%3.4 $396.75 12/31/20192,480,000 shares $856.29 million +0.8%3.0%3.4 $345.28 REGN Short Interest - Frequently Asked Questions What is Regeneron Pharmaceuticals' current short interest? Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 1,720,000 shares of REGN short. Learn More on Regeneron Pharmaceuticals' current short interest. What is a good short interest ratio for Regeneron Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. REGN shares currently have a short interest ratio of 3.0. Learn More on Regeneron Pharmaceuticals's short interest ratio. Which institutional investors are shorting Regeneron Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Regeneron Pharmaceuticals: XR Securities LLC, Concourse Financial Group Securities Inc., SG Americas Securities LLC, Point72 DIFC Ltd, Cubist Systematic Strategies LLC, Millennium Management LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, Torno Capital LLC, Point72 DIFC Ltd, Hsbc Holdings PLC, NINE MASTS CAPITAL Ltd, and XR Securities LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Regeneron Pharmaceuticals' short interest increasing or decreasing? Regeneron Pharmaceuticals saw a decline in short interest during the month of October. As of October 15th, there was short interest totaling 1,720,000 shares, a decline of 0.6% from the previous total of 1,730,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Regeneron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies compare to Regeneron Pharmaceuticals: Amgen Inc. (1.75%), Vertex Pharmaceuticals Incorporated (1.67%), Gilead Sciences, Inc. (1.33%), Alnylam Pharmaceuticals, Inc. (3.83%), Biogen Inc. (2.12%), BeiGene, Ltd. (1.56%), Royalty Pharma plc (3.78%), United Therapeutics Co. (5.01%), Incyte Co. (3.86%), BioMarin Pharmaceutical Inc. (2.94%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Regeneron Pharmaceuticals stock? Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. REGN shares are trading down $89.87 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Regeneron Pharmaceuticals? A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further. How often is Regeneron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies AMGN Short Interest Data VRTX Short Interest Data GILD Short Interest Data ALNY Short Interest Data BIIB Short Interest Data BGNE Short Interest Data RPRX Short Interest Data UTHR Short Interest Data INCY Short Interest Data BMRN Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REGN) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REGN Stock Alerts